Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3.
Identifieur interne : 000A36 ( PubMed/Corpus ); précédent : 000A35; suivant : 000A37Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3.
Auteurs : Hui Hui Wong ; To Sing Fung ; Shouguo Fang ; Mei Huang ; My Tra Le ; Ding Xiang LiuSource :
- Virology [ 1096-0341 ] ; 2018.
English descriptors
- KwdEn :
- Animals, Cell Line, Humans, Interferon Regulatory Factor-3 (chemistry), Interferon Regulatory Factor-3 (genetics), Interferon Regulatory Factor-3 (metabolism), Proteasome Endopeptidase Complex (genetics), Proteasome Endopeptidase Complex (metabolism), Protein Binding, Protein Domains, Proteolysis, SARS Virus (genetics), SARS Virus (metabolism), Severe Acute Respiratory Syndrome (genetics), Severe Acute Respiratory Syndrome (metabolism), Severe Acute Respiratory Syndrome (virology), Signal Transduction, Ubiquitin (metabolism), Viral Regulatory and Accessory Proteins (genetics), Viral Regulatory and Accessory Proteins (metabolism).
- MESH :
- chemical , chemistry : Interferon Regulatory Factor-3.
- chemical , genetics : Interferon Regulatory Factor-3, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins.
- chemical , metabolism : Interferon Regulatory Factor-3, Proteasome Endopeptidase Complex, Ubiquitin, Viral Regulatory and Accessory Proteins.
- genetics : SARS Virus, Severe Acute Respiratory Syndrome.
- metabolism : SARS Virus, Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
- Animals, Cell Line, Humans, Protein Binding, Protein Domains, Proteolysis, Signal Transduction.
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) is an inefficient inducer of interferon (IFN) response. It expresses various proteins that effectively circumvent IFN production at different levels via distinct mechanisms. Through the construction of recombinant IBV expressing proteins 8a, 8b and 8ab encoded by SARS-CoV ORF8, we demonstrate that expression of 8b and 8ab enables the corresponding recombinant viruses to partially overcome the inhibitory actions of IFN activation to achieve higher replication efficiencies in cells. We also found that proteins 8b and 8ab could physically interact with IRF3. Overexpression of 8b and 8ab resulted in the reduction of poly (I:C)-induced IRF3 dimerization and inhibition of the IFN-β signaling pathway. This counteracting effect was partially mediated by protein 8b/8ab-induced degradation of IRF3 in a ubiquitin-proteasome-dependent manner. Taken together, we propose that SARS-CoV may exploit the unique functions of proteins 8b and 8ab as novel mechanisms to overcome the effect of IFN response during virus infection.
DOI: 10.1016/j.virol.2017.12.028
PubMed: 29294448
Links to Exploration step
pubmed:29294448Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3.</title>
<author><name sortKey="Wong, Hui Hui" sort="Wong, Hui Hui" uniqKey="Wong H" first="Hui Hui" last="Wong">Hui Hui Wong</name>
<affiliation><nlm:affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China; Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fung, To Sing" sort="Fung, To Sing" uniqKey="Fung T" first="To Sing" last="Fung">To Sing Fung</name>
<affiliation><nlm:affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fang, Shouguo" sort="Fang, Shouguo" uniqKey="Fang S" first="Shouguo" last="Fang">Shouguo Fang</name>
<affiliation><nlm:affiliation>School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore; Agricultural School, Yangtze University, 266 Jingmilu, Jingzhou City, Hubei Province 434025, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Huang, Mei" sort="Huang, Mei" uniqKey="Huang M" first="Mei" last="Huang">Mei Huang</name>
<affiliation><nlm:affiliation>School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Le, My Tra" sort="Le, My Tra" uniqKey="Le M" first="My Tra" last="Le">My Tra Le</name>
<affiliation><nlm:affiliation>Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Ding Xiang" sort="Liu, Ding Xiang" uniqKey="Liu D" first="Ding Xiang" last="Liu">Ding Xiang Liu</name>
<affiliation><nlm:affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore. Electronic address: dxliu0001@163.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29294448</idno>
<idno type="pmid">29294448</idno>
<idno type="doi">10.1016/j.virol.2017.12.028</idno>
<idno type="wicri:Area/PubMed/Corpus">000A36</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A36</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3.</title>
<author><name sortKey="Wong, Hui Hui" sort="Wong, Hui Hui" uniqKey="Wong H" first="Hui Hui" last="Wong">Hui Hui Wong</name>
<affiliation><nlm:affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China; Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fung, To Sing" sort="Fung, To Sing" uniqKey="Fung T" first="To Sing" last="Fung">To Sing Fung</name>
<affiliation><nlm:affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fang, Shouguo" sort="Fang, Shouguo" uniqKey="Fang S" first="Shouguo" last="Fang">Shouguo Fang</name>
<affiliation><nlm:affiliation>School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore; Agricultural School, Yangtze University, 266 Jingmilu, Jingzhou City, Hubei Province 434025, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Huang, Mei" sort="Huang, Mei" uniqKey="Huang M" first="Mei" last="Huang">Mei Huang</name>
<affiliation><nlm:affiliation>School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Le, My Tra" sort="Le, My Tra" uniqKey="Le M" first="My Tra" last="Le">My Tra Le</name>
<affiliation><nlm:affiliation>Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Liu, Ding Xiang" sort="Liu, Ding Xiang" uniqKey="Liu D" first="Ding Xiang" last="Liu">Ding Xiang Liu</name>
<affiliation><nlm:affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore. Electronic address: dxliu0001@163.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Virology</title>
<idno type="eISSN">1096-0341</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Interferon Regulatory Factor-3 (chemistry)</term>
<term>Interferon Regulatory Factor-3 (genetics)</term>
<term>Interferon Regulatory Factor-3 (metabolism)</term>
<term>Proteasome Endopeptidase Complex (genetics)</term>
<term>Proteasome Endopeptidase Complex (metabolism)</term>
<term>Protein Binding</term>
<term>Protein Domains</term>
<term>Proteolysis</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (genetics)</term>
<term>Severe Acute Respiratory Syndrome (metabolism)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Signal Transduction</term>
<term>Ubiquitin (metabolism)</term>
<term>Viral Regulatory and Accessory Proteins (genetics)</term>
<term>Viral Regulatory and Accessory Proteins (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Interferon Regulatory Factor-3</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Interferon Regulatory Factor-3</term>
<term>Proteasome Endopeptidase Complex</term>
<term>Viral Regulatory and Accessory Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Interferon Regulatory Factor-3</term>
<term>Proteasome Endopeptidase Complex</term>
<term>Ubiquitin</term>
<term>Viral Regulatory and Accessory Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Protein Binding</term>
<term>Protein Domains</term>
<term>Proteolysis</term>
<term>Signal Transduction</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome coronavirus (SARS-CoV) is an inefficient inducer of interferon (IFN) response. It expresses various proteins that effectively circumvent IFN production at different levels via distinct mechanisms. Through the construction of recombinant IBV expressing proteins 8a, 8b and 8ab encoded by SARS-CoV ORF8, we demonstrate that expression of 8b and 8ab enables the corresponding recombinant viruses to partially overcome the inhibitory actions of IFN activation to achieve higher replication efficiencies in cells. We also found that proteins 8b and 8ab could physically interact with IRF3. Overexpression of 8b and 8ab resulted in the reduction of poly (I:C)-induced IRF3 dimerization and inhibition of the IFN-β signaling pathway. This counteracting effect was partially mediated by protein 8b/8ab-induced degradation of IRF3 in a ubiquitin-proteasome-dependent manner. Taken together, we propose that SARS-CoV may exploit the unique functions of proteins 8b and 8ab as novel mechanisms to overcome the effect of IFN response during virus infection.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29294448</PMID>
<DateCompleted><Year>2018</Year>
<Month>04</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>515</Volume>
<PubDate><Year>2018</Year>
<Month>02</Month>
</PubDate>
</JournalIssue>
<Title>Virology</Title>
<ISOAbbreviation>Virology</ISOAbbreviation>
</Journal>
<ArticleTitle>Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3.</ArticleTitle>
<Pagination><MedlinePgn>165-175</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0042-6822(17)30442-7</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2017.12.028</ELocationID>
<Abstract><AbstractText>Severe acute respiratory syndrome coronavirus (SARS-CoV) is an inefficient inducer of interferon (IFN) response. It expresses various proteins that effectively circumvent IFN production at different levels via distinct mechanisms. Through the construction of recombinant IBV expressing proteins 8a, 8b and 8ab encoded by SARS-CoV ORF8, we demonstrate that expression of 8b and 8ab enables the corresponding recombinant viruses to partially overcome the inhibitory actions of IFN activation to achieve higher replication efficiencies in cells. We also found that proteins 8b and 8ab could physically interact with IRF3. Overexpression of 8b and 8ab resulted in the reduction of poly (I:C)-induced IRF3 dimerization and inhibition of the IFN-β signaling pathway. This counteracting effect was partially mediated by protein 8b/8ab-induced degradation of IRF3 in a ubiquitin-proteasome-dependent manner. Taken together, we propose that SARS-CoV may exploit the unique functions of proteins 8b and 8ab as novel mechanisms to overcome the effect of IFN response during virus infection.</AbstractText>
<CopyrightInformation>Copyright © 2017 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>Hui Hui</ForeName>
<Initials>HH</Initials>
<AffiliationInfo><Affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China; Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fung</LastName>
<ForeName>To Sing</ForeName>
<Initials>TS</Initials>
<AffiliationInfo><Affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fang</LastName>
<ForeName>Shouguo</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore; Agricultural School, Yangtze University, 266 Jingmilu, Jingzhou City, Hubei Province 434025, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Mei</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Le</LastName>
<ForeName>My Tra</ForeName>
<Initials>MT</Initials>
<AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Ding Xiang</ForeName>
<Initials>DX</Initials>
<AffiliationInfo><Affiliation>South China Agricultural University, Guangdong Province Key Laboratory Microbial Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People's Republic of China; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, 637551, Singapore. Electronic address: dxliu0001@163.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>12</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Virology</MedlineTA>
<NlmUniqueID>0110674</NlmUniqueID>
<ISSNLinking>0042-6822</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050838">Interferon Regulatory Factor-3</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054334">Viral Regulatory and Accessory Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber>
<NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050838" MajorTopicYN="N">Interferon Regulatory Factor-3</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054334" MajorTopicYN="N">Viral Regulatory and Accessory Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">IFN antagonist</Keyword>
<Keyword MajorTopicYN="Y">IRF3</Keyword>
<Keyword MajorTopicYN="Y">ORF8</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV</Keyword>
<Keyword MajorTopicYN="Y">Ubiquitin-dependent degradation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>11</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2017</Year>
<Month>12</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>12</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>1</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2018</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>1</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29294448</ArticleId>
<ArticleId IdType="pii">S0042-6822(17)30442-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.virol.2017.12.028</ArticleId>
<ArticleId IdType="pmc">PMC7112132</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Virol. 2008 May;82(9):4471-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18305050</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem J. 2009 Apr 28;420(1):1-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19382893</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS Lett. 2006 Jun 26;580(15):3643-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16753150</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Feb;79(4):2079-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15681410</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12885-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16912115</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2007 Feb 5;358(1):136-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16979681</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2000 Oct;81(Pt 10):2341-2364</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10993923</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Interferon Cytokine Res. 2003 Apr;23(4):209-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12856333</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Dec;79(23):14909-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16282490</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antiviral Res. 2014 Sep;109:97-109</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24995382</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2007 Nov 2;282(44):32208-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17761676</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2014 Aug;88(16):8936-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24872591</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2009 Oct;83(20):10322-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19656876</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virol J. 2014 Dec 07;11:209</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25481026</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS J. 2007 Aug;274(16):4211-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17645546</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Top Microbiol Immunol. 2007;316:193-205</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17969449</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Pathog. 2015 Oct 29;11(10):e1005215</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26513244</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2008 Jan;82(1):335-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17942531</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2016 Feb;489:252-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26773386</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2007 Apr 25;361(1):18-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17316733</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2009 May 10;387(2):402-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19304306</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2009 Jun 12;284(24):16202-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19380580</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2011 Feb 18;6(2):e17192</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21364999</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2002 Jun 21;277(25):22304-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11940575</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2001 May 18;276(20):17515-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11278557</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2007 Aug 1;196(3):405-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17597455</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2009 Oct 30;388(4):621-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19686699</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nucleic Acids Res. 2006;34(17):4816-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16971454</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Viruses. 2012 Jun;4(6):980-1010</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22816036</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2007 Dec;81(24):13876-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17928347</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Microbes Infect. 2016 Apr 20;5:e39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27094905</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1992 Oct;66(10):6143-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1527853</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2006 Jun;7(6):598-605</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16699525</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Genes. 2011 Feb;42(1):37-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20976535</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1996 Mar 15;217(2):517-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8610443</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Mol Cell Biol. 2011 Oct;3(5):283-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22028379</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Res. 2008 Nov;18(11):1096-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18711448</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microbes Infect. 2011 Feb;13(2):179-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21035562</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2008 Aug 1;181(3):1780-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18641315</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mol Cell Biol. 1999 Apr;19(4):2465-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10082512</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2008 Apr;133(1):113-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18045721</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2005 Dec;5(12):941-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16322747</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2007 Jan;81(2):548-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17108024</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 Jun;76(11):5532-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11991981</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2004 Jul;30(3):211-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15135736</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2007 Sep 30;366(2):277-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17531282</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Soc Trans. 2008 Jun;36(Pt 3):453-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18481980</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Immunity. 2006 Sep;25(3):373-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16979569</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1991 Dec;185(2):911-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1962461</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rev Immunol. 2001;19:623-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11244049</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2007 May 25;282(21):15325-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17395583</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Immunol. 2006 Oct 15;177(8):5059-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17015689</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Diseases. 2016 Jul 25;4(3):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28933406</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS Lett. 2005 Apr 25;579(11):2387-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15848177</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2008 Jul 5;376(2):379-89</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18452964</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol Methods. 2009 Sep;160(1-2):48-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19409420</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2007 Nov;81(21):11620-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17715225</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2009 Apr;83(8):3977-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19176627</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Interferon Cytokine Res. 2004 Jul;24(7):388-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15296649</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 1995 Dec 29;83(7):1091-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8548797</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2008 Sep 12;283(37):25660-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18635538</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mol Cell Biol. 1998 May;18(5):2986-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9566918</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2015 Oct;89(20):10532-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26269185</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Sci Rep. 2015 Dec 03;5:17554</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26631542</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2014 May;88(9):4866-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24522921</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2007 Sep;81(18):9812-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17596301</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Immunol. 2003 May;4(5):491-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12692549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2006 Oct 10;354(1):132-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16876844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS One. 2009 Dec 17;4(12):e8342</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20020050</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Chemother. 2008 Apr;14(2):86-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18622669</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A36 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000A36 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:29294448 |texte= Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:29294448" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |